Literature DB >> 31055567

Spontaneous Regression of Cervical Intraepithelial Neoplasia 2: A Meta-analysis.

Jin Zhang1, Chun-Xue Lu2.   

Abstract

BACKGROUND: Cervical intraepithelial neoplasia (CIN) is a precancerous condition that, if progresses, can cause cervical cancer. Less severe forms such as CIN1 regress spontaneously for most of the cases, but for high-grade CIN (CIN2 or CIN3), have higher potentials for progression.
OBJECTIVE: Aim of the present study was to obtain reliable estimates of spontaneous regression and progression rates of CIN2.
METHODS: Data were extracted from eligible studies identified after literature search in electronic databases, and meta-analyses were performed by pooling the regression and progression rates reported by these studies. Meta-regression analyses were performed for the identification of factors affecting regression rate.
RESULTS: Sixteen studies (1,481 patients; 14.86 months [95% CI 9.25-20.48] follow-up; 28.23 years [95% CI 25.07-31.39] age) were included in the meta-analysis. Overall regression rate in these conservatively observed patients was 42.66% (95% CI 35.41-49.91), but regression rate was higher in studies that recruited patients with CIN2 (50.85% [95% CI 36.11-65.60]) in comparison with those that recruited patients without discrimination of CIN2 with CIN3 (36.31% [95% CI 27.67-44.95]. Progression rate in CIN2 patients was 10.28% [95% CI 3.72-16.84]). Age was significantly negatively associated with regression rate (coefficient -1.72 [-3.53 to 0.10]; p = 0.061).
CONCLUSION: Spontaneous regression rate of CIN2 is considerably high, especially in younger years.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Cervical cancer; Cervical intraepithelial neoplasia 2; Meta-analysis; Spontaneous regression

Mesh:

Year:  2019        PMID: 31055567     DOI: 10.1159/000497286

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  11 in total

1.  Regression rate of high-grade cervical intraepithelial lesions in women younger than 25 years.

Authors:  Anne Ehret; Victoria Naomi Bark; Anne Mondal; Tanja Natascha Fehm; Monika Hampl
Journal:  Arch Gynecol Obstet       Date:  2022-07-21       Impact factor: 2.493

2.  Possible role of negative human papillomavirus E6/E7 mRNA as a predictor of regression of cervical intraepithelial neoplasia 2 lesions in hr-HPV positive women.

Authors:  Maria Teresa Bruno; Nazario Cassaro; Salvatore Giovanni Vitale; Arianna Guaita; Sara Boemi
Journal:  Virol J       Date:  2022-05-27       Impact factor: 5.913

3.  Safety of Conservative Management of High-Grade Squamous Intraepithelial Lesion in Women Under 30 Years Old.

Authors:  Mariana K Bonas; Michelle G Discacciati; Hisa M Videira; Lucas A Cavalcante; Julio C Teixeira; Diama B Vale
Journal:  Womens Health Rep (New Rochelle)       Date:  2022-06-22

Review 4.  False Negative Results in Cervical Cancer Screening-Risks, Reasons and Implications for Clinical Practice and Public Health.

Authors:  Anna Macios; Andrzej Nowakowski
Journal:  Diagnostics (Basel)       Date:  2022-06-20

5.  Natural history of histologically confirmed high-grade cervical intraepithelial neoplasia during pregnancy: meta-analysis.

Authors:  Cheng Chen; Yu Xu; Wu Huang; Yi Du; Cui Hu
Journal:  BMJ Open       Date:  2021-08-20       Impact factor: 3.006

6.  Rapid and ultrasensitive detection of circulating human papillomavirus E7 cell-free DNA as a cervical cancer biomarker.

Authors:  Phetploy Rungkamoltip; Sasithon Temisak; Kitiya Piboonprai; Deanpen Japrung; Pattanapong Thangsunan; Saranya Chanpanitkitchot; Woraphot Chaowawanit; Nutthaporn Chandeying; Siriwan Tangjitgamol; Tawin Iempridee
Journal:  Exp Biol Med (Maywood)       Date:  2020-12-13

7.  Prevalence of high-grade dysplasia in cytology-negative, HPV-positive cervical cancer screening.

Authors:  Stephanie M Peace; Ashley J Jennings
Journal:  Arch Gynecol Obstet       Date:  2021-09-25       Impact factor: 2.493

8.  Blimp-1 is a prognostic indicator for progression of cervical intraepithelial neoplasia grade 2.

Authors:  Mayumi Saito; Aarthi Rajesh; Carrie Innes; Rachael van der Griend; Peter Fitzgerald; Bryony Simcock; Peter Sykes; Merilyn Hibma
Journal:  J Cancer Res Clin Oncol       Date:  2022-04-06       Impact factor: 4.322

9.  Full genotyping and FAM19A4/miR124-2 methylation analysis in high-risk human papillomavirus-positive samples from women over 30 years participating in cervical cancer screening in Örebro, Sweden.

Authors:  Malin Kaliff; Gabriella Lillsunde Larsson; Gisela Helenius; Mats G Karlsson; Lovisa Bergengren
Journal:  PLoS One       Date:  2022-09-22       Impact factor: 3.752

10.  Conservative management of women with cervical intraepithelial neoplasia grade 2 in Denmark: a cohort study.

Authors:  M Skorstengaard; E Lynge; J Suhr; G Napolitano
Journal:  BJOG       Date:  2020-01-22       Impact factor: 6.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.